BMC Urol.2015 Dec;15(1):15. doi: 10.1186/s12894-015-0015-8. Epub 2015 Mar 14.A novel surgical management for male infertility secondary to m
BMC Urol.2015 Dec;15(1):15. doi: 10.1186/s12894-015-0015-8. Epub 2015 Mar 14.A novel surgical management for male infertility secondary to midline prostatic cyst.
Cheng G1,Liu B,Song Z,Xu A,Song N,Wang Z.Author informationAbstractBACKGROUND:
To summary the procedure and experience of a novel surgical management for male infertility secondary to midline prostatic cyst (MPC).METHODS:
From February 2012 to February 2014, 12 patients were diagnosed with PMC by semen analysis, seminal plasma biochemical analysis, transrectal ultrasonography (TRUS), and pelvic magnetic resonance imaging (MRI). All patients underwent the transurethral unroofing of MPC using resectoscope, the dilation of ejaculatory duct, and the irrigation of seminal vesicle using seminal vesiculoscope. All patients were followed up at least 3months after operation.RESULTS:
Preoperative semen analyses of 12 patients showed oligoasthenozoospermia (5/12) or azoospermia (7/12), low semen volume (0-1.9mL), and low pH level (5.5-7.0). Preoperative seminal plasma biochemical analyses showed reduced semen fructose. TURS and MRI revealed a cyst lesion located in the midline of prostatic. After 3months follow up, the semen quality of 80% patients (4/5) with oligoasthenozoospermia improved obviously. The spermatozoa were present in the semen in 5 of 7 cases with azoospermia. In one patient, the spermatozoa occurred in the urine after ejaculation.CONCLUSIONS:
Surgical management using transurethral resectoscopy and seminal vesiculoscopy is effective, minimally invasive, and safe for male infertility secondary to MPC.